{"title":"赭石属的化学成分和生物活性:微型综述","authors":"Essam Abdel-Sattar, Riham A. El-Shiekh","doi":"10.1016/j.phytol.2024.07.005","DOIUrl":null,"url":null,"abstract":"<div><p>Natural products have historically served as a rich source of potential remedies for cancer, a disease that is projected to become the leading cause of mortality. <em>Ochrosia</em> metabolites are potent cytotoxic drugs due to their ability to interact with nucleic acids. The scope of this review screens key features of the biological activities and phytochemical compositions of the genus <em>Ochrosia</em>. A comprehensive coverage of the literature has been conducted, revealing that alkaloids are the predominant metabolites, characterized by their noteworthy biological activities. <em>Ochrosia</em> plants also contain flavonoids, triterpenes, coumarins, resinol derivatives, and phenolic acids. Several pharmacological effects were reported, including cytotoxic, anti-inflammatory, antiviral, antiplasmodial, and antimicrobial activities. Investigation of the biological activities of ellipticines found potent anti-cancer properties, and several ellipticine derivatives have been the subject of clinical trials. Of particular interest, they have exhibited significant cytotoxic activity against various cell lines, including human breast carcinoma, leukemia cells, neuroblastoma cells, and glioblastoma cells. The ellipticine family of compounds exerts their biological activity <em>via</em> several modes of action, such as intercalation with DNA, topoisomerase II inhibition, interaction with the p53 transcription factor, kinase inhibition, bio-oxidation, and adduct formation. Overall, these studies highlight their diverse therapeutic potential in various types of cancer, indicating their promising role as antineoplastic agents.</p></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"62 ","pages":"Pages 92-111"},"PeriodicalIF":1.3000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chemical composition and biological activities of genus Ochrosia: A mini review\",\"authors\":\"Essam Abdel-Sattar, Riham A. El-Shiekh\",\"doi\":\"10.1016/j.phytol.2024.07.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Natural products have historically served as a rich source of potential remedies for cancer, a disease that is projected to become the leading cause of mortality. <em>Ochrosia</em> metabolites are potent cytotoxic drugs due to their ability to interact with nucleic acids. The scope of this review screens key features of the biological activities and phytochemical compositions of the genus <em>Ochrosia</em>. A comprehensive coverage of the literature has been conducted, revealing that alkaloids are the predominant metabolites, characterized by their noteworthy biological activities. <em>Ochrosia</em> plants also contain flavonoids, triterpenes, coumarins, resinol derivatives, and phenolic acids. Several pharmacological effects were reported, including cytotoxic, anti-inflammatory, antiviral, antiplasmodial, and antimicrobial activities. Investigation of the biological activities of ellipticines found potent anti-cancer properties, and several ellipticine derivatives have been the subject of clinical trials. Of particular interest, they have exhibited significant cytotoxic activity against various cell lines, including human breast carcinoma, leukemia cells, neuroblastoma cells, and glioblastoma cells. The ellipticine family of compounds exerts their biological activity <em>via</em> several modes of action, such as intercalation with DNA, topoisomerase II inhibition, interaction with the p53 transcription factor, kinase inhibition, bio-oxidation, and adduct formation. Overall, these studies highlight their diverse therapeutic potential in various types of cancer, indicating their promising role as antineoplastic agents.</p></div>\",\"PeriodicalId\":20408,\"journal\":{\"name\":\"Phytochemistry Letters\",\"volume\":\"62 \",\"pages\":\"Pages 92-111\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874390024001034\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390024001034","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
天然产品历来是治疗癌症的潜在药物的丰富来源,而癌症预计将成为导致死亡的主要原因。赭石代谢物因其与核酸相互作用的能力而成为有效的细胞毒性药物。本综述的研究范围包括赭石属植物的生物活性和植物化学成分的主要特征。通过对文献的全面研究,我们发现生物碱是最主要的代谢产物,具有显著的生物活性。赭石属植物还含有黄酮类、三萜类、香豆素、树脂醇衍生物和酚酸。据报道,它们具有多种药理作用,包括细胞毒性、抗炎、抗病毒、抗浆膜炎和抗菌活性。对鞣花素生物活性的研究发现,鞣花素具有很强的抗癌特性,有几种鞣花素衍生物已经成为临床试验的对象。尤其令人感兴趣的是,它们对各种细胞系,包括人类乳腺癌、白血病细胞、神经母细胞瘤细胞和胶质母细胞瘤细胞,都具有显著的细胞毒活性。鞣花碱系列化合物通过多种作用模式发挥其生物活性,如与 DNA 的插层作用、拓扑异构酶 II 抑制、与 p53 转录因子的相互作用、激酶抑制、生物氧化和加合物形成。总之,这些研究凸显了它们在各类癌症中的多种治疗潜力,表明它们有望成为抗肿瘤药物。
Chemical composition and biological activities of genus Ochrosia: A mini review
Natural products have historically served as a rich source of potential remedies for cancer, a disease that is projected to become the leading cause of mortality. Ochrosia metabolites are potent cytotoxic drugs due to their ability to interact with nucleic acids. The scope of this review screens key features of the biological activities and phytochemical compositions of the genus Ochrosia. A comprehensive coverage of the literature has been conducted, revealing that alkaloids are the predominant metabolites, characterized by their noteworthy biological activities. Ochrosia plants also contain flavonoids, triterpenes, coumarins, resinol derivatives, and phenolic acids. Several pharmacological effects were reported, including cytotoxic, anti-inflammatory, antiviral, antiplasmodial, and antimicrobial activities. Investigation of the biological activities of ellipticines found potent anti-cancer properties, and several ellipticine derivatives have been the subject of clinical trials. Of particular interest, they have exhibited significant cytotoxic activity against various cell lines, including human breast carcinoma, leukemia cells, neuroblastoma cells, and glioblastoma cells. The ellipticine family of compounds exerts their biological activity via several modes of action, such as intercalation with DNA, topoisomerase II inhibition, interaction with the p53 transcription factor, kinase inhibition, bio-oxidation, and adduct formation. Overall, these studies highlight their diverse therapeutic potential in various types of cancer, indicating their promising role as antineoplastic agents.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.